[Enterococcal endocarditis, a model of therapeutic difficulty].
Fernández Guerrero
M L
ML
Departamento de Medicina, Fundación Jiménez Díaz, Universidad Autónoma de Madrid.
Núñez García
A
A
D000667:Ampicillin / Q000494:pharmacology / Q000627:therapeutic use; D000668:Ampicillin Resistance; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D016983:Enterococcus / Q000187:drug effects*; D005839:Gentamicins / Q000008:administration & dosage; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology / Q000627:therapeutic use; D011446:Prospective Studies; D013307:Streptomycin / Q000008:administration & dosage; D014640:Vancomycin / Q000494:pharmacology / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D010406:Penicillins; D014640:Vancomycin; D000667:Ampicillin; D013307:Streptomycin